NCT05611151 Real-time Computer-Aided Detection of Colonic Adenomas With NEC WISE VISION® Endoscopy Status COMPLETED Phase NA
NCT05611034 In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung Status RECRUITING Phase PHASE1
NCT05609396 Interventions to Improve Bowel Cancer Screening Uptake in Ireland: a 2x2 Factorial Trial Status COMPLETED Phase NA
NCT05605522 A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours Status TERMINATED Phase PHASE1
NCT05601388 Role of IMP3 Expression in Colorectal Carcinoma: An Immunohistochemical Study Status UNKNOWN Phase N/A
NCT05600309 A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study Status COMPLETED Phase PHASE3
NCT05597384 Assessment of Autologous Blood Marker Localization in Laparoscopic Colorectal Cancer Surgery Status UNKNOWN Phase NA
NCT05594576 Comparison of the ENDOCUFF VISION® Endoscopy Cap Coupled With GI GENIUS™ Artificial Intelligence Compared to Each Device Alone in Improving Colonic Adenoma Detection Rate During Colonoscopy Status COMPLETED Phase NA
NCT05593328 Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation Status COMPLETED Phase PHASE2
NCT05592886 A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers Status RECRUITING Phase NA
NCT05592626 A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05589675 Evaluation of a New Invitation Procedure to the French Organized Colorectal Cancer Screening Program Status COMPLETED Phase NA
NCT05587452 Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence Status UNKNOWN Phase N/A
NCT05585034 Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT05581004 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05579353 The Roles of Exosomal Circ-LRBA and 451/CRTC2 Signaling Axis in Colorectal Cancer Status RECRUITING Phase N/A
NCT05578287 RC48 Plus Tislelizumab, Low-dose Capecitabine and Celecoxib for HER2-positive Metastatic Colorectal Cancer Status RECRUITING Phase PHASE2
NCT05576896 Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory Status TERMINATED Phase PHASE2